Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000276·INOVIO PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock · CUSIP: 45773H409
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 3,266,260 · Class: 6.2%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 2,802,530 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000276
- Form type
- SCHEDULE 13G
- Filer
- INOVIO PHARMACEUTICALS, INC.
- CIK
- CIK 1055726
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership